Home › Trial NCT00869206
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
- Trial IDNCT00869206
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorAlliance for Clinical Trials in Oncology
- Enrollment1822
- Start date2009-03
- ConditionsBreast Adenocarcinoma · DS Stage I Plasma Cell Myeloma · DS Stage II Plasma Cell Myeloma · Metastatic Malignant Neoplasm to the Bone · Pain · Musculoskeletal Complication
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.